MEBOÔÚ¼¤¹âìî°ß´´ÃæÖеÄÖÎÁÆ×÷ÓÃ
ÁøÖÝÊÐÁøÌúÖÐÐÄÒ½ÔºÕûÐÎÍâ¿Æ Ö쵤±ë ÇØºèÖ¾ Áú ê¿
¡¾ÕªÒª¡¿Ä¿µÄ ÊӲ켫Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸ࣨMEBO£©¶Ô¼¤¹âìî°ßÊõºó´´ÃæÓúºÏµÄЧ¹û¡£ÒªÁì ½«120Àý¼¤¹âìî°ßÊõºóµÄ»¼Õߣ¬Ëæ»ú·ÖΪÖÎÁÆ×éºÍ¶ÔÕÕ×飬¸÷60Àý£¬ÖÎÁÆ×éÊõºóÔÚ´´ÃæÍ¿Ä¨MEBO£¬Ã¿Ìì4´Î~6´Î£¬±£³Ö´´Ãæ³ÊʪÈó״ֱ̬ÖÁ´´ÃæÓúºÏ£»¶ÔÕÕ×é´´ÃæÍ¿ÒÔºìÃ¹ËØÈí¸à£¬Ã¿Ìì4´Î~6´Î£¬Ö±ÖÁ´´ÃæÓúºÏ¡£ÊÓ²ì2×éÔÚÊõºóµÄֹʹЧ¹û¡¢´´ÃæÓúºÏʱ¼ä¡¢É«ËØÀä¾²¼°ÆäÏûÍ˵ȷ½ÃæµÄÁÆÐ§¡£½á¹û ÖÎÁÆ×éÊõºóÌÛÍ´ºÍ´´ÃæÓúºÏʱ¼äÓë¶ÔÕÕ×é±ÈÁ¦ÓÐÏÔÖø²îÒ죨P£¼0.01£©£»Êõºó´´ÃæÉ«ËØÀä¾²Çé¿öÁ½×éÏà±È²îÒìÎÞͳ¼ÆÑ§ÒâÒ壬µ«ÔÚ´´ÃæÉ«ËØÀä¾²µÄÏûÍËʱ¼äÉÏ£¬ÖÎÁÆ×é±È¶ÔÕÕ×éÃ÷ÏÔËõ¶Ì£¬²îÒìÏÔÖø£¨P£¼0.01£©¡£½áÂÛ MEBO¶Ô¼¤¹âìî°ßÊõºó´´Ãæ¾ßÓпìËÙֹʹ¡¢Ëõ¶Ì´´ÃæÓúºÏʱ¼ä¡¢´Ù½øÉ«ËØÀä¾²ÏûÍ˵Ä×÷Óã¬ÊÇ´¦Öü¤¹âÊõºó´´ÃæµÄÀíÏëÒªÁì¡£
¡¾Òªº¦´Ê¡¿¼«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸ࣻ¼¤¹â£»ìî°ß£»ºìÃ¹ËØÈí¸à
¡¾Abstract¡¿Objective To observe the therapeutic effect of MEBO Wound Ointment £¨MEBO£©in the treatment of surgical sites after spot area laser therapy. Method The 120 patients after spot area laser therapy were randomly and evenly divided into treatment group and control group. In treatment group, MEBO Wound Ointment was administered after surgery for 4-6 times a day, keeping the surgical sites moist until wound healing; In control group, the surgical sites were applied with erythromycin ointment for 4-6 times a day until healing. And then, the indicators of therapeutic effects, such as the postoperative pain relief, wound healing days, pigment deposition and fading were observed in two groups. Results Compared to control group, the postoperative pain relief and wound healing days in treatment group had significant differences(P£¼0.01); pigment deposition in two groups showed no statistical difference, but the fading time of pigment in treatment group was significantly shorter than that in control group (P£¼0.01). Conclusion MEBO Wound Ointment in the treatment of surgical wounds after spot area laser therapy is effective on rapid relief of pain, shortening healing time and promoting pigment fading, thus is an ideal therapeutic approach in the treatment of surgical wounds after laser therapy.
¡¾Key words¡¿MEBO Wound Ointment; Laser; Spot area surgery; Erythromycin ointment
½üÄêÀ´£¬Ó¦Óü¤¹âìî°ßµÄÖÎÁÆÒªÁìÒѾ¹ã·ºÓ¦Óã¬ÓÈÆäÒÔYAG¼¤¹âìî°ßÒªÁìΪ´ú±í£¬Ð§¹ûÈ·ÇС£ÖÎÁÆÔÀíÊÇÀûÓü¤¹âµÄÑ¡ÔñÐÔ¹âÈÈ×÷ÓÃÖÎÁÆÉ«Ëز¡±ä£¬ÓŵãÊÇÄÜÖÆÖ¹´ó²¿ÃÅÆ¤·ô×éÖ¯µÄËðÉË´Ó¶ø²»Ò×·ºÆðñ£ºÛ¡£µ«¼¤¹âÖÎÁƺó´´ÃæµÄ´¦ÖÃÒ²·Ç³£Òªº¦£¬Èç¹û´´ÃæÓÃÒ©²»Í×£¬²»¹âÑÓ³¤ÓúºÏʱ¼ä£¬ÉõÖÁ»áÔì³ÉѬȾ£¬µ¼ÖÂñ£ºÛÐγɡ£Ä¿Ç°¼¤¹âÖÎÁƺóµÄ´´ÃæÓÃÒ©±ÈÁ¦ÔÓÂÒ£¬ÓÐÍâÍ¿µâ·ü¡¢¿µ¸´Ð¡¢Ë«ÑõË®µÈÒ©Ë®£¬Ò²ÓÐÍâÍ¿ºìÃ¹ËØ¡¢½ðÃ¹ËØ¡¢ÉÕÉ˸àµÈÖÖÖÖÒ©¸àÕß¡£ÎÒ¿ÆÓÚ1996Äê10ÔÂÖÁ1999Äê10Ô¼䣬¶Ô120Àý¼¤¹âìî°ßÊõºó´´ÃæµÄ´¦Ö÷ֱð½ÓÄÉMEBOºÍºìÃ¹ËØÈí¸àͿĨ´´Ã棬²¢½øÐÐÁËÁÆÐ§ÊÓ²ìºÍ±ÈÁ¦·ÖÎö¡£ÏÖ±¨µÀÈçÏ£º
1.×ÊÁÏÓëÒªÁì
1.1.Ò»°ã×ÊÁÏ
½«¼¤¹âìî°ßÖÎÁƵÄ120Àý»¼Õߣ¬Ëæ»ú·ÖΪÁ½×飺ÖÎÁÆ×éºÍ¶ÔÕÕ×飬¸÷60Àý¡£ÖÎÁÆ×é½ÓÄɼ«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸ࣨMEBO£©ÔËÓÃʪÐÔÒ½Ò©¼¼ÊõÖÎÁÆ£»¶ÔÕÕ×é½ÓÄɺìÃ¹ËØÈí¸àÍâÍ¿£¬Á½×é¾ù½ÓÄÉ´´ÃæÌ»Â¶ÁÆ·¨ÖÎÁÆ¡£Ì«Ìïðë58Àý£¬È¸°ß37Àý£¬¿§·È°ß25Àý£»Å®ÐÔ98Àý£¬ÄÐÐÔ22Àý£»ÄêÁä14Ëê~46Ë꣬ƽ¾ù28.5Ë꣬ÉíÌ彡¿µ£¬¾ùΪÃÅÕﻼÕß¡£
1.2.ÒªÁì
½ÓÄÉͨÀýµâ¾Æ¡¢¾Æ¾«Ïû¶¾´´Ã棬ÊõÇø¾Ö²¿ÓÃ0.5%Àû¶à¿¨ÒòÉúÀíÑÎË®ÈÜÒº½þÈóÂé×í£¬È»ºóÓÃË«²¨³¤Âö³åµ÷Q¼¤¹â£¨³¤´º¾°»úËùÉú²úµÄYQ400-A/BI£©½øÐÐÖÎÁÆ£¬¼¤¹âÁÙ´²²ÎÊýµÄÉ趨ÒÀ¾Ý²¡±äµ÷Õû£¬¼¤¹âµÄ²¨³¤¡¢ÄÜÁ¿Ãܶȡ¢¹â°ß¡¢Âö¿íºÍƵÂÊӦƾ¾Ý»¼ÕßµÄÄêÁä¡¢·ôÉ«¡¢²¡±ä²¿Î»¡¢²¡±äÑÕÉ«½øÐÐÉ趨£»±¾¼¤¹âÓÐ532 nmºÍ1064 nmÁ½¸ö²¨³¤¡£¼¤¹âÖÎÁÆÍê±Ïºó£¬Æ¾¾ÝƤ·ôÔλÔÙÉúÒ½ÁƼ¼Êõ½øÐд´Ãæ´¦Ö㺲»Ê¹Óô̼¤ÐÔÏû¶¾Òº£¬ÓÃÎÞ¾úÉúÀíÑÎË®ÇåÏ´½à¾»¡£È»ºóÖÎÁÆ×é½ÓÄɼ«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸àÍâÍ¿£¬¿ÉÓÃѹÉà°å»òÃÞÇ©½«Æä¾ùÔÈͿĨÓÚ´´Ã棬ºñ1 mm~2 mm£¬4 h~6 h»»Ò©1´Î£¬Ã¿´ÎͿҩǰ½«´´Ãæ²ÐÁôµÄÒ©ÎïºÍÉø³öÎïÇå³ý½à¾»£¬¿ÉÏÈÓÃÎÞ¾úÉúÀíÑÎË®ÇåÏ´´´Ã棬ȻºóÍ¿¼«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸࣬Ӧʱ¿Ì±£³Ö´´Ãæ³ÊʪÈó״̬£¬·ÀÖ¹´´Ãæ½áð裬ֱÖÁ´´ÃæÓúºÏ¡£¶ÔÕÕ×é½ÓÄÉ1%ºìÃ¹ËØÈí¸àÍâÍ¿£¨Í¿Ò©ºñ¶È¡¢»»Ò©Ê±¼ä¡¢´´ÃæÇåÏ´µÈºÍÖÎÁÆ×éÏàͬ£©£¬Ö±ÖÁ´´ÃæÓúºÏ¡£Á½×é¾ùÊÓ²ì¼Ç¼´´ÃæÓúºÏʱ¼ä¡¢ÊõºóÌÛÍ´Çé¿ö£¬²¢Ëæ·Ã6¸öÔÂÖÁ9¸öÔ£¬ÊÓ²ì´´ÃæÉ«ËØÀä¾²Çé¿ö¡£´´ÃæÓúºÏºóÖö¸À»¼Õß×¢Òâ·Àɹ£¬ÒÔÖÆÖ¹É«ËØÀä¾²£¬Í¬Ê±·þÓÃάÉúËØc¼õÇáÉ«ËØÀä¾²¡£
1.3.ÊÓ²ìÖ¸±ê
¢Ù´´ÃæÓúºÏʱ¼ä£»¢ÚÊõºóÌÛÍ´£»¢ÛÉ«ËØÀä¾²¡£
1.4.ͳ¼ÆÑ§´¦ÖÃ
Ó¦ÓüÆËã»úSPSS 11.0ͳ¼ÆÈí¼þ½øÐÐͳ¼ÆÑ§´¦Ö㬼ÆÁ¿×ÊÁϾùÒÔx(_)¡ÀsÌåÏÖ£¬½ÓÄÉt¼ìÑé²â¶¨ÆäÏÔÖøÐÔ£»¼ÆÊý×ÊÁÏÒÔÂÊÌåÏÖ£¬×é¼äµÄ±ÈÁ¦½ÓÄɦÖ2¼ìÑ飬P£¼0.05Ϊ²îÒìÓÐͳ¼ÆÑ§ÒâÒå¡£
2.½á¹û
MEBO×éµÄ´´ÃæÓúºÏʱ¼äÒÔ¼°´´ÃæÊõºóÌÛÍ´Çé¿öÓëºìÃ¹ËØÈí¸à×éÏà±È£¬P£¼0.01£¬ÓÐÏÔÖøÐÔ²îÒ죺MEBOÄܹ»Ã÷ÏÔ¼õÇá´´ÃæÌÛÍ´ÒÔ¼°´Ù½ø´´ÃæÓúºÏ£¨¼û±í1¡¢±í2£©¡£Á½×é´´ÃæÓúºÏºó·ºÆðÉ«ËØÀä¾²µÄ²îÒìÎÞͳ¼ÆÑ§ÒâÒ壨P£¾0.05£©£¬µ«ÊÇ´ÓÉ«ËØÀ侲ʱ¼äµÄÏûÍËÉÏ¿´£ºMEBO×éµÄ´´ÃæÉ«ËØÀä¾²Á¬ÐøÊ±¼ä±ÈºìÃ¹ËØÈí¸à×éÃ÷ÏÔËõ¶Ì£¨P£¼0.01£¬¼û±í3£©¡£
3.ÌÖÂÛ
3.1.´Ù½ø´´ÃæÓúºÏ
MEBOÊÇÒ»ÖÖ¿ò¼ÜÈí¸à¼Á£¬º¬ÓлÆÜË¡¢»Æ°Ø¡¢·äÀ¯¡¢ÂéÓ͵ÈÉí·Ö£¬²»½öÄÜ¿¹Ñ¬È¾¡¢ìÉú¼¡¡¢»îѪ»¯ðö£¬ÎªÔλ¸Éϸ°ûÔÙÉúÐÞ¸´µÞÔìÌõ¼þ£¬´Ù½ø´´ÃæµÄÓúºÏ£¬¶øÇÒÈí¸àÖеĦÂ-¹ÈçÞ´¼¿É¸ÄÉÆ¾Ö²¿Î¢Ñ»·£¬¼õÇá¾Ö²¿×éÖ¯ÓÙÖÍËðÉË£¬Ê¹×éÖ¯×î´óÏ޶ȵصõ½ËÕÐÑÉú³¤£¬ÉÏÆ¤Ï¸°ûѸËÙÔöÖ³£¬´Ó¶ø´Ùʹ´´ÃæÓúºÏ[1]¡£±¾ÊµÑ鼤¹âÖÎÁƺóµÄ´´ÃæÀàËÆÓÚdz¢ò¶ÈÉÕÌÌÉË´´Ã棬¶øMEBOÔÚÉÕÉË»òÌÌÉËµÈÆ¤·ôËðÉËÖÐÒѾµÃµ½¼«Îª¹ã·ºµÄÓ¦Óã¬ÇÒЧ¹ûÁ¼ºÃ£¬ÊÇÖÎÁÆÉÕÉË»òÌÌÉËµÈÆ¤·ôËðÉ˵ÄÊ×Ñ¡ÓÃÒ©£¬ËùÒÔ½«MEBOÔËÓÃÔÚ¼¤¹âìî°ßÊõºóµÄ´´ÃæÊÇÓÐÒÀ¾ÝµÄ¡£ÓÉÓÚMEBOÔËÓù㷺ÇÒ±»²»Í£µØÍÚ¾ò£¬Òò´ËMEBOÔÚÕûÐÎÃÀÈÝרҵҲµÃµ½ºÜºÃµÄÓ¦Óá£È磺CO2¼¤¹âÖÎÁÆÆ¤·ô»òð¤Ä¤ÉϵÄðà»ò׸ÉúÎïµÄ´´Ãæ[2]£»Ë«²¨³¤Âö³åµ÷QND:YAG¼¤¹âÖÎÁÆ»úϴü¡¢ÑÛÏß¡¢ÎÆÉí¡¢Ãæ²¿È¸°ßµÈ´´Ãæ[3]£»ÒÔ¼°Ö²Æ¤ºó¹©Çø´´ÃæµÄÖÎÁƵȵȣ¬¶¼Ö¤Ã÷MEBO¶ÔƤ·ô´´ÉËÓÐÁ¼ºÃµÄÓúºÏ×÷Óá£
3.2.´Ù½øÉ«ËØÀä¾²µÄÏûÍË
ÑÇÖÞÈËÔÚÆ¤·ôÊÜËðºóÈÝÒ×·ºÆðÉ«ËØÀä¾²£¬µ«´ó¶à¿ÉÒÔ×ÔÐÐÏûÍË£¬Ê±¼äÊÇ·Ç·×Æç£¬Ò»°ãΪ2¸öÔÂ~6¸öÔ£¬ÉÙÊý»¼ÕßÄÑÒÔÉõÖÁºã¾Ã²»ÍË£¬ÊÇÆ¤·ôÖÎÁÆ£¨Ä¥Ï÷£¬¼¤¹âµÈ£©µÄ³£¼û²¢·¢Ö¢£¬»ÆÖÖÈ˸üΪÃ÷ÏÔ¡£Æ¤·ôÔâµ½ÖÖÖÖ´´ÉË£¨²ÁÉË¡¢ÉÕÌÌÉË¡¢Ä¥Ï÷¡¢¼¤¹âµÈ£©ÓúºÏºó£¬ÓÐ85%µÄ»¼Õß·ºÆðÉ«ËØÀä¾²[4]£¬Ò²Óм«ÉÙÊý»¼ÕßÔÚ´´ÃæÓúºÏÈ´ÁôÏÂÉ«ËØÍÑʧ¡£É«ËØÀä¾²µÄ»úÖÆÄ¿Ç°ÉÐδÍêÈ«Ã÷ÁË£¬µ«´Ó±¾ÁÙ´²Ñо¿¿ÉÒÔ¿´µ½£ºÁ½×éÖÎÁÆÒªÁì¶Ô´´ÃæÓúºÏºó·ºÆðÉ«ËØÀä¾²µÄ²îÒìËäÎÞͳ¼ÆÑ§ÒâÒ壬µ«MEBO×éµÄ´´ÃæÉ«ËØÀä¾²ÏûÍËʱ¼ä±ÈºìÃ¹ËØÈí¸à×éÃ÷ÏÔËõ¶Ì¡£ÎÒÃÇ¿¼ÂÇÉ«ËØÀä¾²¿ÉÄÜÓë´´ÃæµÄÓúºÏʱ¼äÓйأ¬´´ÃæÔ½ÔçÓúºÏ£¬¶øÇÒÓúºÏÖÊÁ¿Ô½ºÃ£¬É«ËØÀä¾²µÄÏûÍ˾ÍÔ½¿ì¡£ÁíÍ⣬´´ÃæÉ«ËØÀä¾²ÏûÍËÓëMEBOÉí·ÖÊÇ·ñÓйأ¬Óдý½øÒ»²½ÇóÖ¤¡£
3.3.»º½â´´ÃæÌÛÍ´
Àû¶à¿¨Òò£¨¼ÓÉöÉÏÏÙËØ£©µÄ¾ÖÂéЧ¹ûÒ»°ã»áÁ¬Ðø1 h~2 h£¬¶ÔÕÕ×éÔÚ¾ÖÂéЧ¹û½â³ýºó»áÓÐ¶ÌÆÚÀ±Í´¸ÐÊÜ£¨5 min~30 min£©£¬ºìÃ¹ËØÈí¸àµÄ´Ì¼¤×÷Óþ³£ÒýÆð¶àÊý»¼ÕßÖÎÁÆÇøÆ¤·ô×ÆÍ´£¬¶øÖÎÁÆ×éÍâÍ¿¼«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸àºó£¬³ý7ÀýÓÐ¶ÌÆÚµÄÀ±Í´¸ÐÊÜÍ⣬ÆäÓà¾ùÎÞÌÛÍ´¸ÐÊÜ¡£¶øÇÒ¸ÐÊÜ¶ÌÆÚÌÛÍ´µÄ7Àý»¼Õߣ¬Ò²ÔÚÍâÓü«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸àÔ¼10 minºóÌÛÍ´Ïûʧ£¬¾·ÖÎöºó·¢ÏÖÊÇÒòÕâ7Àý»¼ÕßÉ«°ßÃæ»ý½Ï´ó£¬¼¤¹âÖÎÁÆÊ±¼ä½Ï³¤£¬Áè¼Ý2 h£¬ÒѾ¹ýÁ˾ÖÂéÁ¬ÐøÊ±¼ä£¬´´Ãæ·ºÆðÀ±Í´¸ÐÊÜ£¬µ«¾¹ýÍâÍ¿¼«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸àºóÌÛÍ´»º½â£¬ÕâÊÇÒòΪ¼«Ôÿª»§Æ½Ì¨ÊªÈóÉÕÉ˸à¾ßÓÐֹʹ×÷ÓÃ[5]£¨Ô¼Ðè10 min²ÅÆø·¢»Óֹʹ×÷Óã©¡£MEBOֹʹµÄ»úÀí£º£¨1£©MEBOÓë´´ÃæµÄ»µËÀ±À½â×éÖ¯·¢Éú»¯Ñ§·´Ó³£¬¶øÓëÓлîÁ¦µÄ×éÖ¯²»·¢Éú·´Ó³£¬·´¶ø¿ÉÔÚÆäÉÏÐγɱ£»¤Ä¤£¬±£»¤Ì»Â¶µÄÉñ¾Ä©ÉÒ£¬µ½´ïֹʹЧ¹û£»£¨2£©Ó¦ÓÃMEBOºó¿Éʹ´´ÃæÊªÈó£¬ÇÒ½Ó½üÉúÀí»·¾³£¬ÖÆÖ¹Á˸ÉÔï½áðèµÄÊÕËõ¶øÇ£À´´Ãæ×éÖ¯ËùÖµÄÌÛÍ´£»£¨3£©MEBOµÄ±£»¤´´ÃæºÍÒýÁ÷µÈ×÷Ó㬼õÇáÁË´´ÃæµÄÑ×Ö¢·´Ó³£¬Ê¹¾Ö²¿×é֯ˮÖ×¼õÇᣬ¶ÔÉñ¾Ä©ÉÔµÄѹÆÈºÍ´Ì¼¤¼õÉÙ£¬ÌÛÍ´×ÔÈ»¼õÇá¡£
²Î¿¼ÎÄÏ×
[1]ÐìÈÙÏé.ÉÕÉËÒ½ÁƼ¼ÊõÀ¶Æ¤±¾£¨µÚ1¾í£©[M].ÖйúÒ½Ò©¿Æ¼¼³öÊéÉ磬2000£º45~46.
[2]Ñî¾ü£¬»Ý½Ý£¬Ðìºì. MEBOÓëºìÃ¹ËØÑÛ¸àÖÎÁÆCO2¼¤¹â´´ÃæµÄÁÆÐ§·ÖÎö[J]. ÖйúÉÕÉË´´ÑñÔÓÖ¾,2008,20(4):314~316.
[3]Àîïʢ£¬Áõ²ßÀø£¬ÒóÓ£¬µÈ. MEBOÔÚ¼¤¹âÃÀÈÝÖÎÁÆÖеÄÓ¦ÓÃ[J]. ÖйúÉÕÉË´´ÑñÔÓÖ¾,2007,19(1):72~74.
[4]Plensdorf S,Martinez J.Common pigmentation disorders[J]. American Family Physician,2009,79(2):21~23.
[5]Íõ¹úÔ¨£¬ÕŽðÁú.MEBOÁªºÏºì¹âÕÕÉäÖÎÁÆÉÕÉË´´ÃæµÄÁÆÐ§ÊÓ²ì[J].ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬2009£¬21£¨4£©£º270~271.